- Home
- NRXP vs PCLA Comparison
NRXP vs PCLA Comparison
Compare NRXP & PCLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NRXP
- PCLA
- Stock Information
- Founded
- NRXP 2015
- PCLA 2008
- Country
- NRXP United States
- PCLA Japan
- Employees
- NRXP N/A
- PCLA N/A
- Industry
- NRXP Biotechnology: Pharmaceutical Preparations
- PCLA Building Products
- Sector
- NRXP Health Care
- PCLA Consumer Discretionary
- Exchange
- NRXP Nasdaq
- PCLA Nasdaq
- Market Cap
- NRXP 32.6M
- PCLA 32.3M
- IPO Year
- NRXP N/A
- PCLA 2025
- Fundamental
- Price
- NRXP $3.27
- PCLA $1.50
- Analyst Decision
- NRXP Strong Buy
- PCLA
- Analyst Count
- NRXP 4
- PCLA 0
- Target Price
- NRXP $28.50
- PCLA N/A
- AVG Volume (30 Days)
- NRXP 298.7K
- PCLA 1.8M
- Earning Date
- NRXP 08-13-2025
- PCLA 01-01-0001
- Dividend Yield
- NRXP N/A
- PCLA N/A
- EPS Growth
- NRXP N/A
- PCLA N/A
- EPS
- NRXP N/A
- PCLA N/A
- Revenue
- NRXP N/A
- PCLA $5,475,228.00
- Revenue This Year
- NRXP N/A
- PCLA N/A
- Revenue Next Year
- NRXP N/A
- PCLA N/A
- P/E Ratio
- NRXP N/A
- PCLA N/A
- Revenue Growth
- NRXP N/A
- PCLA 40.19
- 52 Week Low
- NRXP $1.10
- PCLA $0.37
- 52 Week High
- NRXP $6.01
- PCLA $9.80
- Technical
- Relative Strength Index (RSI)
- NRXP 66.15
- PCLA N/A
- Support Level
- NRXP $2.90
- PCLA N/A
- Resistance Level
- NRXP $3.61
- PCLA N/A
- Average True Range (ATR)
- NRXP 0.28
- PCLA 0.00
- MACD
- NRXP -0.03
- PCLA 0.00
- Stochastic Oscillator
- NRXP 64.59
- PCLA 0.00
About NRXP NRX Pharmaceuticals Inc.
NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. The company is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.
About PCLA PicoCELA Inc. American Depositary Shares
PicoCELA Inc specializes in manufacturing, installing, and servicing enterprise wireless mesh solutions. The company generates revenue from two main sources: product equipment sales, and Software as a Service (SaaS) and maintenance services. The company develops the PCWL series of mesh Wi-Fi access points, which utilize its proprietary PicoCELA Backhaul Engine (PBE) technology to enable wireless communication. The company outsources manufacturing and sells these devices directly to customers through distributors. Additionally, the company offers a cloud portal service in a SaaS model, allowing users to monitor connectivity and traffic at their access points. This platform also supports the installation of proprietary edge-computing software into the devices.